Fast Company September 27, 2024 Read the full article >> “So no one else uses chatgpt as an unpaid therapist?” TikTok user Ash Donner asks in a video. While her friends seem shocked by her confession, she’s not alone. A growing number of people are turning to ChatGPT to ask for help navigating friendships, romantic relationships,[…]
Read the full press release >> August 21, 2024 09:00 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–OM1, the leader in real-world evidence generation and insights for life sciences, proudly announces the appointment of Catherine Richards, PhD, MPH, as its first President. Richards will oversee the Product, Engineering, Clinical Informatics, Client Services, Data Science, and Research teams. Her leadership will[…]
DermWorld Aug 09, 2024 Read the full article >> Experts employ real-world data to understand GPP, diagnose it early, and target treatment. SUN08 – Phenotyping Generalized Pustular Psoriasis (GPP): Findings of a Collaborative Artificial Intelligence (AI) Initiative One of the more frustrating aspects of having a dermatologic disorder, in addition to the pain and suffering,[…]
Read the full press release >> July 30, 2024 09:00 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–OM1, the leader in real-world insights synthesis and evidence generation for life sciences supporting population and personalized data insights, evidence generation through advanced validated AI platforms, big deep clinical data, registries, and globally recognized thought leadership today announced the new[…]
June 24, 2024 Pharma’s Almanac Read the full article >> Rich Gliklich, M.D., Chief Executive Officer and founder, OM1 One impactful way will be through platforms that enable data and study automation. In recent remarks, FDA Commissioner Dr. Robert Califf argued that there is tremendous opportunity to simplify and digitize data collection to create more pragmatic[…]
